Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06236165
PHASE2
Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
Investigating the efficacy, safety, and molecular mechanism of N-acetylcysteine supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2024-02-14
Completion Date
2025-01-22
Last Updated
2026-07-22
Healthy Volunteers
No
Conditions
Interventions
DRUG
N-acetylcysteine
Patients will receive oral N-acetylcysteine 600 mg twice daily in addition to supportive treatment, for 3 months.
Locations (1)
Faculty of Pharmacy, Tanta University
Tanta, Egypt